https://hydroxyfasudilinhibito....r.com/smith-magenis-
SAC, a safe and effective treatment for RIAs, proves advantageous when combined with ICH, especially when perioperative dual antiplatelet therapy (DAPT) is utilized. For wide-neck RIAs, SAC should be the method of choice, in addition. The presence of ischemic complications is a factor in predicting poor clinical outcomes. Considering the limited sample and potential for retrospective bias in this study, further validation is crucial, ideally through a larger-scale investigation or a randomized controlle